Get started
Author

Rudi Bao

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
2003 · Muthu Selvakumaran, Debra A Pisarcik, et al. · PubMed · 311
Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.
2003 · Denise C Connolly, Rudi Bao, et al. · PubMed · 310
Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
2010 · Xiong Cai, Hai-Xiao Zhai, et al. · Journal of Medicinal Chemistry · 264
Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2012 · Changgeng Qian, Cheng-Jung Lai, et al. · Clinical Cancer Research · 249
CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
2010 · Cheng-Jung Lai, Rudi Bao, et al. · Cancer Research · 217
PDF
CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy
2009 · Rudi Bao, Cheng-Jung Lai, et al. · Clinical Cancer Research · 116
PDF
Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.
2003 · Callinice D Capo-chichi, Isabelle H Roland, et al. · PubMed · 85
Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
2004 · Sherri L. Stewart, Troy D. Querec, et al. · Cancer Research · 63
Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer
2009 · Rudi Bao, Cheng-Jung Lai, et al. · Molecular Cancer Therapeutics · 60
LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein
1999 · Abbas Abdollahi, Rudi Bao, et al. · Oncogene · 59
Use of a Surrogate Marker (Human Secreted Alkaline Phosphatase) to Monitor in Vivo Tumor Growth and Anticancer Drug Efficacy in Ovarian Cancer Xenografts
2000 · Rudi Bao, Muthu Selvakumaran, et al. · Gynecologic Oncology · 31
Generation of Tumors in Transgenic Mice Expressing the SV40 T Antigen Under the Control of Ovarian-Specific Promoter 1
2003 · Kenneth Garson, Elizabeth Macdonald, et al. · Journal of the Society for Gynecologic Investigation · 26
Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter
2002 · Rudi Bao, Muthu Selvakumaran, et al. · Gynecologic Oncology · 21
Abstract 3063: Discovery of a third-generation EGFR inhibitor, which is highly selective and potent against both resistant and activating EGFR mutations for NSCLC therapy
2016 · Rudi Bao, Peng Gao, et al. · Cancer Research · 11
Novel compounds in the treatment of lung cancer: current and developing therapeutic agents
2011 · Rudi Bao, Chan · Journal of Experimental Pharmacology · 9
PDF
NVP-LBH589, a novel histone deacetylase inhibitor, activates caspase-3 and induces apoptosis of human tumor cells in vivo
2004 · Peter Lassota, Erik J. Sorensen, et al. · Cancer Research · 3
The radiation sensitization effect of newly discovered EGFR specific inhibitor HS-10182 in human lung cells.
2016 · Ningbo Liu, Yang Chen, et al. · Journal of Clinical Oncology · 1
Abstract 3249: Design and synthesis of imidazopyridine derivatives as novel HSP90 inhibitors for the treatment of cancer
2011 · Xiong Cai, Hai-Xiao Zhai, et al. · Cancer Research · 1
Abstract 2615: Antitumor activity of a dual PI3K and HDAC inhibitor in hematologic cancer models
2011 · Rudi Bao, Dagong Wang, et al. · Cancer Research · 1
Data from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2023 · Fushun Fan, Pei Liu, et al.
Supplementary Figures 1 - 9 from Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
2023 · Changgeng Qian, Cheng-Jung Lai, et al.
Figure S6 from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2023 · Fushun Fan, Pei Liu, et al.
Table S1 from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2023 · Fushun Fan, Pei Liu, et al.
PDF
Figure S4 from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2023 · Fushun Fan, Pei Liu, et al.
Table S2 from A Dual PI3K/HDAC Inhibitor Induces Immunogenic Ferroptosis to Potentiate Cancer Immune Checkpoint Therapy
2023 · Fushun Fan, Pei Liu, et al.
PDF
Works count: 50
Citation count: 1,838
H-index: 13
I10-index: 14
Year
Topic
Type